Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Whole tomato lipid extract is a dietary supplement derived from the lipophilic (fat-soluble) fraction of the entire tomato fruit (Solanum lycopersicum). It contains a complex mixture of bioactive compounds including lycopene, β-carotene, flavonoids, ketosamines (Fru-His), and other carotenoids and polyphenols. The primary mechanism of action is believed to be antioxidant and anti-inflammatory activity. Preclinical studies have shown that it can reduce oxidative stress, inflammation, and hyperplasia in models of benign prostatic hyperplasia (BPH), particularly in the context of obesity. Clinical studies suggest potential benefits for improving urinary symptoms in BPH patients without significant side effects. The product may also modulate cell cycle regulation via inhibition of STAT-3 phosphorylation and support cardiovascular health by improving cholesterol profiles[1][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on whole tomato lipid extract.